Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient

Dry Needling Clinical Trial

Official title:

Harms Associated With Dry Needling Provided During Patient Care in Colorado by Physical Therapists

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04040218
• Other study ID #: 1069837-1
• Status: Completed
• Phase: N/A
• Start date: April 1, 2017
• Est. completion date: April 30, 2017

Study information

• Verified date: July 2019
• Source: Regis University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A retrospective analysis of responses following a descriptive survey to investigate the benefits and harms associated with dry needling as provided by a physical therapists in CO

Description:

Two surveys were completed to identify the reported harms by physical therapists in the provision of dry needling in Colorado, and by patients who received dry needling from physical therapists in Colorado in April 2017. Retrospective analysis of the data (de-identified) was completed to provide a representative reporting on harms associated with the dry needling provided and received for patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2607
• Est. completion date: April 30, 2017
• Est. primary completion date: April 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Physical therapists providing dry needling to patients in Colorado

• Patients who had received dry needling from Physical Therapists in Colorado

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Dry Needling
• Harm

Intervention

Procedure:
• Dry Needling
Dry needling is utilized by multiple practitioners to address impairments in neuromusculoskeletal function, often related to pain and loss of mobility. Dry needling, according the American Physical Therapy Association (APTA), is defined as a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments

Locations

Country	Name	City	State
United States	Regis University	Denver	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
Regis University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survey analysis of harm data	Harm - "any ill-effect, no matter how small, that was unintended." Further delineation was made that minor/insignificant complaints/harms were defined as short term soreness less than 24 hours and more than 24 hours, bruising and light-headedness, and major/significant harm was defined infection or pneumothorax (PTX).	As reported during the four week survey time frame